OXM vs GH vs RL vs EXAS

For growth investors, Guardant Health, Inc.

(GH) is the stronger pick with 32. 9% revenue growth year-over-year, versus -3. 5% for Oxford Industries, Inc. (OXM). Oxford Industries, Inc. (OXM) offers the better valuation at 7. 7x trailing P/E (20. 4x forward), making it the more compelling value choice. Analysts rate Oxford Industries, Inc. (OXM) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Oxford Industries, Inc.

(OXM) is the cheapest at 7. 7x versus Ralph Lauren Corporation at 30. 5x. On forward P/E, Oxford Industries, Inc. is actually cheaper at 20. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Ralph Lauren Corporation wins at 1. 19x versus Oxford Industries, Inc. 's 2. 64x — a reasonable growth-adjusted valuation.

Over the past 5 years, Ralph Lauren Corporation (RL) delivered a total return of +164.

4%, compared to -39. 3% for Oxford Industries, Inc. (OXM). Over 10 years, the gap is even starker: EXAS returned +1669% versus OXM's +2. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Exact Sciences Corporation (EXAS) is the lower-risk stock at 0.

05β versus Oxford Industries, Inc. 's 1. 74β — meaning OXM is approximately 3207% more volatile than EXAS relative to the S&P 500. On balance sheet safety, Oxford Industries, Inc. (OXM) carries a lower debt/equity ratio of 72% versus 105% for Exact Sciences Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Guardant Health, Inc.

(GH) is pulling ahead at 32. 9% versus -3. 5% for Oxford Industries, Inc. (OXM). On earnings-per-share growth, the picture is similar: Exact Sciences Corporation grew EPS 80. 3% year-over-year, compared to 6. 7% for Guardant Health, Inc.. Over a 3-year CAGR, GH leads at 29. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Ralph Lauren Corporation (RL) is the more profitable company, earning 10.

5% net margin versus -42. 4% for Guardant Health, Inc. — meaning it keeps 10. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RL leads at 13. 2% versus -44. 4% for GH. At the gross margin level — before operating expenses — EXAS leads at 69. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Ralph Lauren Corporation (RL) is the more undervalued stock at a PEG of 1. 19x versus Oxford Industries, Inc. 's 2. 64x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Oxford Industries, Inc. (OXM) trades at 20. 4x forward P/E versus 582. 8x for Exact Sciences Corporation — 562. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GH: 44. 3% to $133. 14.

In this comparison, OXM (6.

0% yield), RL (0. 9% yield) pay a dividend. GH, EXAS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Exact Sciences Corporation (EXAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), +1669% 10Y return). Oxford Industries, Inc. (OXM) carries a higher beta of 1. 74 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EXAS: +1669%, OXM: +2. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OXM (Consumer Cyclical) and GH (Healthcare) and RL (Consumer Cyclical) and EXAS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OXM is a small-cap deep-value stock; GH is a mid-cap high-growth stock; RL is a mid-cap quality compounder stock; EXAS is a mid-cap high-growth stock. OXM, RL pay a dividend while GH, EXAS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.